Patient treatment preference as a predictor of clinical outcomes in subjects with treatment-resistant depression: a comparative effectiveness research trial for antidepressant incomplete and nonresponders with treatment-resistant depression (ASCERTAIN-TRD)
Stefania Chaikali, Clotilde Guidetti, M. Trivedi, R. Waid Shelton et autres
Major depressive disorder (MDD) is a severe and debilitating illness. Despite the available treatments, clinical outcomes remain suboptimal, and hence, it is crucial to identify predictive factors for response. This is a secondary analysis investigating the relationship between treatment preference and response …
us, it, ca (code pays fourni par la source)
3 citations
International Clinical Psychopharmacology